Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | HINT1 | P49773 | 4/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | NT5E | P21589 | 1/20 | 0.47 |
| ▸ | STING1 | Q86WV6 | 3/20 | 0.46 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.46 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.45 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.44 |
| ▸ | PNP | P00491 | 1/20 | 0.44 |
| ▸ | GSK3A | P49840 | 2/20 | 0.44 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.44 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18490509 | 0.90 | ADORA3 (0.57) | ADORA3HINT1HPGDNT5ESTING1 | |
| SCHEMBL16144340 | 0.89 | ADORA3 (0.53) | ADORA3HINT1NT5ESTING1PDE3B | |
| SCHEMBL23171036 | 0.85 | ADORA3 (0.50) | ADORA3HINT1HPGDNT5ESTING1 | |
| SCHEMBL16144341 | 0.84 | ADORA3 (0.51) | ADORA3HINT1HPGDNT5ESTING1 | |
| SCHEMBL22236552 | 0.82 | ADORA3 (0.47) | ADORA3HINT1HPGDNT5ESTING1 | |
| SCHEMBL15588481 | 0.82 | ADORA3 (0.47) | ADORA3HINT1HPGDNT5ESTING1 | |
| SCHEMBL20693191 | 0.82 | FUT5 (0.54) | HINT1NT5ESTING1FUT5PNP | |
| SCHEMBL20611193 | 0.81 | ADORA3 (0.54) | ADORA3HINT1HPGDNT5ESTING1 | |
| SCHEMBL20611229 | 0.81 | ADORA3 (0.52) | ADORA3HINT1HPGDNT5ESTING1 | |
| SCHEMBL15833022 | 0.81 | ADORA3 (0.52) | ADORA3HINT1HPGDNT5ESTING1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3797782-A1 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF FOR USE IN THE TREATMENT OF VIRAL INFECTIONS | Janssen BioPharma, Inc. (US) | 2021-03-31 | — | — | EP | disclosed |